The clinical significance of hematocrit values before and after percutaneous coronary intervention

American Heart Journal

Volumn 158, Issue 6, 2009, Pages 1024-1030

  Maluenda, Gabriel ^a   Lemesle, Gilles ^a   Collins, Sara D ^a   Ben Dor, Itsik ^a   Syed, Asmir I ^a   Torguson, Rebecca ^a   Kaneshige, Kimberly ^a   Xue, Zhenyi ^a   Pakala, Rajbabu ^a   Suddath, William O ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Lindsay, Joseph ^a   Pichard, Augusto D ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL ASSESSMENT; FEMALE; FOLLOW UP; HAZARD RATIO; HEART DEATH; HEART INFARCTION; HEMATOCRIT; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HEMATOCRIT; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PREOPERATIVE CARE; RISK FACTORS; TREATMENT OUTCOME;

EID: 70549106870     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.10.005     Document Type: Article

References (24)

1. Nikolsky E., Aymong E.D., Halkin A., et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol 44 (2004) 547-553
2. Dauerman H.L., Lessard D., Yarzebski J., et al. Bleeding complications in patients with anemia and acute myocardial infarction. Am J Cardiol 96 (2005) 1379-1383
3. Voeltz M.D., Patel A.D., Feit F., et al. Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary intervention. Am J Cardiol 99 (2007) 1513-1517
4. Manoukian S.V., Voeltz M.D., and Eikelboom J. Bleeding complications in acute coronary syndromes and percutaneous coronary intervention: predictors, prognostic significance, and paradigms for reducing risk. Clin Cardiol 30 S2 (2007) II24-II34
5. Ndrepepa G., Berger P.B., Mehilli J., et al. Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point. J Am Coll Cardiol 51 (2008) 690-697
6. Kinnaird T.D., Stabile E., Mintz G.S., et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol 92 (2003) 930-935
7. Reinecke H., Trey T., Wellmann J., et al. Haemoglobin-related mortality in patients undergoing percutaneous coronary interventions. Eur Heart J 24 (2003) 2142-2150
8. Lee P.C., Kini A.S., Ahsan C., et al. Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol 44 (2004) 541-546
9. Steinhubl S.R., Kastrati A., and Berger P.B. Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs. Am Heart J 154 (2007) 3-11
10. Wallace T.W., and Rao S.V. The challenge of defining bleeding among patients with acute coronary syndromes. Clin Cardiol 30 S2 (2007) II16-II23
11. Thygesen K., Alpert J.S., and White H.D. Universal definition of myocardial infarction. J Am Coll Cardiol 50 (2007) 2173-2195
12. Ryan T.J., Bauman W.B., Kennedy J.W., et al. Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 22 (1993) 2033-2054
13. Chesebro J.H., Knatterud G., Roberts R., et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 76 (1987) 142-154
14. Kim P., Dixon S., Eisenbrey A.B., et al. Impact of acute blood loss anemia and red blood cell transfusion on mortality after percutaneous coronary intervention. Clin Cardiol 30 S2 (2007) II35-II43
15. Spencer F.A., Moscucci M., Granger C.B., et al. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction. Circulation 116 (2007) 2793-2801
16. Rao S.V., Jollis J.G., Harrington R.A., et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 292 (2004) 1555-1562
17. Yusuf S., Mehta S.R., Chrolavicius S., et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 354 (2006) 1464-1476
18. Montalescot G., White H.D., Gallo R., et al. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention. N Engl J Med 355 (2006) 1006-1017
19. Stone G.W., Witzenbichler B., Guagliumi G., et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 358 (2008) 2218-2230
20. Levy P.S., Quigley R.L., and Gould S.A. Acute dilutional anemia and critical left anterior descending coronary artery stenosis impairs end organ oxygen delivery. J Trauma 41 (1996) 416-423
21. Mak K.H., Moliterno D.J., Granger C.B., et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol 30 (1997) 171-179
22. Best P.J., Lennon R., Ting H.H., et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 39 (2002) 1113-1119
23. Shaw J.A., Andrianopoulos N., Duffy S., et al. Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents. Cardiovasc Revasc Med 9 (2008) 218-223
24. Weiss G., and Goodnough L.T. Anemia of chronic disease. N Engl J Med 352 (2005) 1011-1023